A woman on Reddit seeks advice when she learns that the child she had with her husband via surrogate isn't biologically her ...

Shares of Hims & Hers were on fire Monday because the FDA's new leader seems to be a fan of the company's business model.

A woman is igniting viral conversation after sharing that her sister is upset with the name she's chosen for her child — ...

Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.

Hims & Hers achieved a 44% YoY increase in Q3 2024, surpassing 2 million active users. Find out what positions HIMS as a key ...

Canaccord raised the firm’s price target on Hims & Hers to $38 from $28 and keeps a Buy rating on the shares. The stock rallied 70% in ...

The thriller author's new book comes amid the anticipated Netflix series adaptation of her novel 'His & Hers' starring Tessa ...

Hims & Hers Health Inc. shares surged 24% to close at fresh record after Hunterbrook Media said the company is poised to be a ...

Hims & Hers' financials are robust, with strong and accelerating revenue growth, growing free cash flow, manageable SBC, and ...

Attendees at amfAR’s Las Vegas gala last month got a sneak peek at this Roberto Cavalli pre-fall collection when designer ...

On Friday, Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $32.15 which represents a slight increase of $1.81 or 5.97% from the prior close of $30.34. The stock opened at ...

Hims & Hers ( HIMS -0.72%) announced this week that it's getting into the nutrition business with bars and shakes. But are ...